UroGen Pharma Ltd. (FRA:UR8)

UroGen Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	855	434	419	192	187	325
Market Cap Growth	96.72%	3.64%	118.57%	2.22%	-42.39%	-47.83%
Enterprise Value	857	307	370	172	92	225
Last Close Price	19.70	-	13.30	7.55	8.05	13.90
PS Ratio	10.40	4.97	5.60	3.18	4.44	33.74
PB Ratio	-8.69	-51.05	-7.10	-2.29	25.34	4.13
P/TBV Ratio	-	-	-	-	25.34	4.13
EV/Sales Ratio	10.33	3.52	4.95	2.85	2.18	23.36
Debt / Equity Ratio	-1.13	-14.19	-1.54	-1.12	0.18	0.03
Asset Turnover	0.40	0.39	0.53	0.50	0.40	0.07
Inventory Turnover	1.46	1.19	1.87	1.67	1.52	-
Quick Ratio	3.47	5.59	4.88	4.71	4.51	5.09
Current Ratio	3.99	6.01	5.42	5.39	5.11	5.39
Return on Equity (ROE)	-	-	-	-	-211.55%	-92.88%
Return on Assets (ROA)	-33.96%	-25.77%	-26.10%	-38.69%	-47.72%	-46.29%
Return on Capital (ROIC)	-101.59%	-79.15%	-179.24%	-479.55%	-105.88%	-52.96%
Return on Capital Employed (ROCE)	-92.60%	-39.90%	-44.60%	-70.80%	-94.80%	-119.50%
Earnings Yield	-16.41%	-28.23%	-22.08%	-53.60%	-51.98%	-32.27%
FCF Yield	-13.77%	-21.60%	-16.54%	-42.88%	-40.17%	-26.90%
Buyback Yield / Dilution	-18.43%	-48.70%	-26.43%	-2.05%	-2.60%	-6.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.